• Colorectal cancer is the third most commonly diagnosed cancer in Australia with a survival rate of 68 per cent.
  • Our research aims to understand all aspects of colorectal cancer to provide comprehensive, evidence based care for patients.
  • Research into why patients react positively or negatively to treatment to better select treatment options and improve survival rates.
  • Since 2006, the St John of God Subiaco Hospital Cancer Unit has treated 2,777 patients with colorectal cancer.
 
  • Improving survival and quality of life after treatment for colorectal cancer.
  • Better estimation of prognosis and treatment response to enable a more individualised treatment approach. 
  • Investigating ways to harness the immune system to fight colorectal cancer and improve response to standard treatments.
 
Director of Colorectal Cancer Research Group
Professor Cameron Platell

Postdoctoral Research Fellow
Dr Melanie McCoy

Clinical Research Nurse
Cheryl Penter

Research Officers
Ms Tracey Lee-Pullen
Dr Chidozie Anyaegbu
Ms Stephanie Austin

Graduate Research Assistants
Dr Timothy Miller, Ms Megan Clarke and Dr Kaija Strautins

Associate Investigators
St John of God Subiaco Hospital:
Mr Michael Levitt, Mr Patrick Tan, Dr Jennifer Ryan, Dr Paul Salama, Dr Daphne Tsoi
Dr Thomas van Hagen, Dr Ru-Wen Teh and Dr Tim Clay

St John of God Murdoch Hospital:
Mr Gregory Makin, Mr Nigel Barwood, Dr Sanjay Mukhedkar and Dr Kynan Feeney

Anyaegbu, C.C, Lee-Pullen, T.F, Miller, T.J., Abel, T.N, Platell, C.F, McCoy, M.J.
Optimisation of multiplex immunofluorescence for a non-spectral fluorescence scanning
system. J Immunol Methods. 2019 Jun 8 [Epub ahead of print]
https://doi:10.1016/j.jim.2019.06.011

Hardcastle, S.J, Hince, D., Jiménez-Castuera, R., Boyle ,T., Cavalheri, V., Makin, G., Tan, P., Salfinger, S,. Tan, J., Mohan, G.R., Levitt, M., Cohen, P.A., Saunders, C., Platell, C.
Promoting physical activity in regional and remote cancer survivors (PPARCS) using
wearables and health coaching: randomised controlled trial protocol. BMJ Open. 2019
May 24;9(5):e028369
https://doi:10.1136/bmjopen-2018-028369

Ng, Z.Q., Levitt, M., Tan, P., Makin, G., Platell, C. Long-term outcomes of surgical management of rectal prolapse. ANZ J Surg. 2019 Jun;89(6): E231-E235
https://doi:10.1111/ans.15264

Maxwell-Smith, C,. Hince, D., Cohen, P.A., Bulsara, M.K., Boyle, T., Platell, C., Tan, P.,Levitt, M., Salama, P., Tan, J., Salfi nger, S., Makin, G., Mohan, G.R.K.A., Jiménez-Castuera,
R., Hardcastle, S.J. A
randomised controlled trial of WATAAP to promote physical activity in colorectal and endometrial cancer survivors. Psychooncology. 2019 Jul;28(7):1420-
1429
https://doi:0.1002/pon.5090

Walker, P.A., Platell, C. Long-term Outcomes of Surgery for Colorectal Cancer: A 20-Year Study. Surg Res. 2019 Mar;235:34-43
https://doi:10.1016/j.jss.2018.09.026

Maxwell-Smith, C., Cohen, P.A., Platell ,C., Tan, P., Levitt, M., Salama, P., Makin, G.B., Tan, J., Salfi nger, S., Kader Ali Mohan, G.R., Kane, R.T., Hince, D., Jiménez-Castuera, R,. Hardcastle , S.J. Wearable Activity Technology And Action-Planning (WATAAP) to promote physical activity in cancer survivors: Randomised controlled trial protocol. SJ. Int J Clin Health Psychol. 2018 May-Aug;18(2):124-132
https://doi:10.1016/j.ijchp.2018.03.003

Miller, T.J., McCoy, M.J., Hemmings, C., Iacopetta, B., Platell, C
.F. Expression of PD-L1 and SOX2 during rectal tumourigenesis: Potential mechanisms for immune escape and tumour cell invasion. Oncol Lett. 2018 Nov;16(5):5761-5768
https://doi:10.3892/ol.2018.9337

Rasmussen, M., Platell, C., Jones, M.
Monitoring excess unplanned return to theatre following colorectal cancer surgery. ANZ J Surg. 2018 Nov;88(11):1168-1173
https://doi:10.1111/ans.14885

Mackowski, A., Levitt, M., Makin, G., Salama, P., Tan, P., Penter, C., Platell ,C
. Anal squamous cell carcinoma: are we improving outcomes? ANZ J Surg. 2018 Oct;88(10):1013-1016
https://doi:0.1111/ans.14745